Among VC firms, New Enterprise Associates had the most exits in healthcare companies in 2014. Venrock also notched an impressive year with healthcare exits including Juno, Coherus, Avalanche and Celladon. On the corporate side of investments, SR One, the corporate venturing unit of GlaxoSmithKline, topped all corporate investors by exit count in 2014. The top 5 was rounded out by Novo Ventures, J&J Development Corp, Novartis Venture Funds and Pfizer Venture Investments, respectively.